Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / May / Examining Sex-Dependent Psychiatric Risks
Neurology Genetics and epigenetics Neurology Molecular Pathology

Examining Sex-Dependent Psychiatric Risks

Sex-dependent genetic risks found for three major mood and psychiatric disorders

By Liv Gaskill 05/04/2021 Quick Read (pre 2022) 1 min read

Share

Previous research suggests there may be sex-dependent risks for several major psychiatric disorders (1). However, according to Jill M. Goldstein, founder and executive director of the Innovation Center on Sex Differences in Medicine at Massachusetts General Hospital, “medicine, essentially, has been built on models of men’s health and male animals. We need to develop our precision medicine models incorporating the effect of sex (2).”

Recognizing the need for a genotype-by-sex (GxS) interaction study, an international collaboration of researchers conducted a large-scale genome-wide study to assess the sex-dependent and sex-specific risks of schizophrenia, major depressive disorder (MDD), and bipolar disorder (3). Though there was some genetic overlap between the sexes, they found significant sex-dependent effects for genes associated with neuronal development and immune and vascular pathway functioning across the disorders.

Heritability estimates differed between males and females for schizophrenia and MDD, but not for bipolar disorder, suggesting there are sex differences in incidence for schizophrenia and MDD. For all disorders, a single nucleotide polymorphism (SNP)-by-sex interaction was found at a locus encompassing NKAIN2 – a gene associated with cognitive ability and risk of schizophrenia. They also found a significant GxS interaction for the STLM gene and a SNP adjacent to AMIGO1.

The authors did note that the study lacked access to detailed clinical data, preventing them from delving deeper into GxS associations with age of onset, symptom type and severity, and cognitive deficits. However, their research still demonstrates a vital call for reform in genetics research.

“Our study underscores the importance of designing large-scale genetic studies that have the statistical power to test for interactions with sex,” said Goldstein (2). “Dissecting the impact of sex, genes, and pathophysiology will identify potential targets for sex-dependent or sex-specific therapeutic interventions – creating more effective therapies for both men and women.”

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. HE Jongsma et al., Lancet Public Health, 4, e229 (2019). PMID: 31054641.
  2. N Brown (2021). Available at: https://bit.ly/3tV8fQD.
  3. GAM Blokland et al., Biol Psych, [Preprint] (2021).

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.